XTRA:SHL

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Siemens Healthineers

Executive Summary

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and distributes imaging, diagnostic, and advanced therapies products and services to healthcare providers worldwide.


Snowflake Analysis

Solid track record with adequate balance sheet.


Similar Companies

Share Price & News

How has Siemens Healthineers's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: SHL has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

-1.8%

SHL

0.9%

DE Medical Equipment

2.1%

DE Market


1 Year Return

10.9%

SHL

20.3%

DE Medical Equipment

2.1%

DE Market

Return vs Industry: SHL underperformed the German Medical Equipment industry which returned 20.4% over the past year.

Return vs Market: SHL exceeded the German Market which returned 3% over the past year.


Shareholder returns

SHLIndustryMarket
7 Day-1.8%0.9%2.1%
30 Day-4.1%-2.8%-0.8%
90 Day16.4%15.1%20.1%
1 Year13.1%10.9%21.8%20.3%4.2%2.1%
3 Yearn/a121.8%117.1%3.7%-4.7%
5 Yearn/a248.4%234.4%10.7%-4.0%

Price Volatility Vs. Market

How volatile is Siemens Healthineers's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Siemens Healthineers undervalued compared to its fair value and its price relative to the market?

9.1%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: SHL (€41.95) is trading below our estimate of fair value (€46.14)

Significantly Below Fair Value: SHL is trading below fair value, but not by a significant amount.


Price To Earnings Ratio

PE vs Industry: SHL is good value based on its PE Ratio (26.9x) compared to the Medical Equipment industry average (53x).

PE vs Market: SHL is poor value based on its PE Ratio (26.9x) compared to the German market (21.1x).


Price to Earnings Growth Ratio

PEG Ratio: SHL is poor value based on its PEG Ratio (2x)


Price to Book Ratio

PB vs Industry: SHL is good value based on its PB Ratio (4.4x) compared to the DE Medical Equipment industry average (4.5x).


Next Steps

Future Growth

How is Siemens Healthineers forecast to perform in the next 1 to 3 years based on estimates from 18 analysts?

13.3%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: SHL's forecast earnings growth (13.3% per year) is above the savings rate (0.2%).

Earnings vs Market: SHL's earnings (13.3% per year) are forecast to grow slower than the German market (22.4% per year).

High Growth Earnings: SHL's earnings are forecast to grow, but not significantly.

Revenue vs Market: SHL's revenue (5.7% per year) is forecast to grow slower than the German market (5.9% per year).

High Growth Revenue: SHL's revenue (5.7% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: SHL's Return on Equity is forecast to be low in 3 years time (16.8%).


Next Steps

Past Performance

How has Siemens Healthineers performed over the past 5 years?

4.2%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: SHL has high quality earnings.

Growing Profit Margin: SHL's current net profit margins (10.4%) are higher than last year (9.9%).


Past Earnings Growth Analysis

Earnings Trend: SHL's earnings have grown by 4.2% per year over the past 5 years.

Accelerating Growth: SHL's earnings growth over the past year (13.8%) exceeds its 5-year average (4.2% per year).

Earnings vs Industry: SHL earnings growth over the past year (13.8%) exceeded the Medical Equipment industry 8.2%.


Return on Equity

High ROE: SHL's Return on Equity (16.4%) is considered low.


Next Steps

Financial Health

How is Siemens Healthineers's financial position?


Financial Position Analysis

Short Term Liabilities: SHL's short term assets (€7.6B) exceed its short term liabilities (€6.0B).

Long Term Liabilities: SHL's short term assets (€7.6B) exceed its long term liabilities (€7.4B).


Debt to Equity History and Analysis

Debt Level: SHL's debt to equity ratio (63.2%) is considered high.

Reducing Debt: Insufficient data to determine if SHL's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: SHL's debt is well covered by operating cash flow (28.4%).

Interest Coverage: SHL's interest payments on its debt are well covered by EBIT (89.2x coverage).


Balance Sheet


Next Steps

Dividend

What is Siemens Healthineers's current dividend yield, its reliability and sustainability?

1.91%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: SHL's dividend (1.91%) is higher than the bottom 25% of dividend payers in the German market (1.26%).

High Dividend: SHL's dividend (1.91%) is low compared to the top 25% of dividend payers in the German market (3.8%).


Stability and Growth of Payments

Stable Dividend: Whilst dividend payments have been stable, SHL has been paying a dividend for less than 10 years.

Growing Dividend: SHL's dividend payments have increased, but the company has only paid a dividend for 2 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonable payout ratio (51.4%), SHL's dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: SHL's dividends in 3 years are forecast to be covered by earnings (51.6% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.6yrs

Average management tenure


CEO

Bernd Montag (51yo)

5.5yrs

Tenure

€3,996,000

Compensation

Dr. Bernhard Montag, also known as Bernd, serves as President and at Chairman of Management Board Siemens at Healthineers AG and has been its Chief Executive Officer and Member of Management Board since 20 ...


CEO Compensation Analysis

Compensation vs Market: Bernd's total compensation ($USD4.52M) is about average for companies of similar size in the German market ($USD5.21M).

Compensation vs Earnings: Bernd's compensation has increased by more than 20% in the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Bernhard Montag
President5.5yrs€4.00mno data
Jochen Schmitz
CFO & Member of Management Board2.58yrs€2.77mno data
Christoph Zindel
Member of Management Board0.75yrno datano data
Marc Koebernick
Head of Investor Relationsno datano datano data
Michel Therin
President of Advanced Therapiesno datano datano data
Martin Fischer
Head of Finance Diagnosticsno datano datano data
Christian Klaussner
Executive Vice President of Financeno datano datano data
Deepak Nath
President of Laboratory Diagnosticsno datano datano data

2.6yrs

Average Tenure

54yo

Average Age

Experienced Management: SHL's management team is considered experienced (2.6 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Norbert Gaus
Deputy Chairman of Supervisory Board2.5yrs€193.00kno data
Karl-Heinz Streibich
Independent Member of Supervisory Board2.33yrs€147.63kno data
Ralf Peter Thomas
Chairman of Supervisory Board0.58yrno datano data
Marion Helmes
Independent Member of Supervisory Board2.33yrs€171.00kno data
Roland Busch
Member of Supervisory Board0.42yrno datano data
Philipp Rösler
Independent Member of Supervisory Board2.33yrs€123.50kno data
Nathalie von Siemens
Member of Supervisory Board2.33yrs€117.93kno data
Andreas Hoffmann
Member of Supervisory Board2.33yrs€201.50kno data
Gregory Sorensen
Independent Member of Supervisory Board2.33yrs€162.50kno data

2.3yrs

Average Tenure

56yo

Average Age

Experienced Board: SHL's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Siemens Healthineers AG's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Siemens Healthineers AG
  • Ticker: SHL
  • Exchange: XTRA
  • Founded:
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: €42.117b
  • Shares outstanding: 997.80m
  • Website: https://www.siemens-healthineers.com

Number of Employees


Location

  • Siemens Healthineers AG
  • Henkestrasse 127
  • Erlangen
  • Bavaria
  • 91052
  • Germany

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
SHLDB (Deutsche Boerse AG)YesOrdinary SharesDEEURMar 2018
SHLWBAG (Wiener Boerse AG)YesOrdinary SharesATEURMar 2018
SHLSWX (SIX Swiss Exchange)YesOrdinary SharesCHCHFMar 2018
SHLXTRA (XETRA Trading Platform)YesOrdinary SharesDEEURMar 2018
SHLDBATS-CHIXE (BATS 'Chi-X Europe')YesOrdinary SharesGBEURMar 2018
SEMH.FOTCPK (Pink Sheets LLC)YesOrdinary SharesUSUSDMar 2018
0PMJLSE (London Stock Exchange)YesOrdinary SharesGBEURMar 2018
SHLETLX (Eurotlx)YesOrdinary SharesITEURMar 2018
SMMN.YOTCPK (Pink Sheets LLC)UNSPONSORED ADRUSUSDMay 2018
SHL1DB (Deutsche Boerse AG)UNSPONSORED ADRDEEURMay 2018

Biography

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and distributes imaging, diagnostic, and advanced therapies products and services to healthcare providers worldwide. The company’s Imaging segment offers magnetic resonance, computed tomography, X-ray, molecular imaging, and ultrasound systems. Its Diagnostics segment provides in-vitro diagnostic products and services to healthcare providers in laboratory, molecular, and point-of-care diagnostics; and workflow solutions and informatics products. The company’s Advanced Therapies segment offers integrated products, solutions, and services for therapy departments of healthcare providers. This segment’s principal products include angiography systems and mobile C-arms. It also provides customer value chain services, including design, maintenance, operational management, training, and education services. Siemens Healthineers AG has a collaboration agreement with MicroPort Scientific Corp. to develop medical imaging equipment used in diagnostics and operating procedures. The company is headquartered in Erlangen, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/07/07 20:50
End of Day Share Price2020/07/07 00:00
Earnings2020/03/31
Annual Earnings2019/09/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.